Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting
Press Releases
April 29, 2025

Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting

– Data include results from COURAGE Phase 3 and COMPOSUR Phase 4 studies of vibegron (GEMTESA®) –

bradford

The Bradford Era

Local & Social